Charles Schwab Investment Management Inc. Purchases 498,417 Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL)
Charles Schwab Investment Management Inc. increased its position in shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) by 43.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,645,787 shares of the company’s stock after acquiring an additional 498,417 shares during the period. […]
Charles Schwab Investment Management Inc. increased its position in shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL – Free Report) by 43.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,645,787 shares of the company’s stock after acquiring an additional 498,417 shares during the period. […]
